Trial Details
TERMINATEDBasic Information
| Clinical ID | c2537 |
|---|---|
| Identifier | NCT03329885 |
| Trial Title | A Study of Experimental Medication BMS-986251, Taken by Mouth, in Healthy Participants and Patients With Average to Very Serious Psoriasis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Rheumatoid Arthritis|Psoriasis|Ankylosing Spondylitis|Inflammatory Bowel Diseases|Nonalcoholic Steatohepatitis |
| Interventions | DRUG: BMS-986251|OTHER: Placebo |
Participant Information
| Sponsor | Bristol-Myers Squibb |
|---|---|
| City | Groningen |
| Country/Region | Netherlands |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2017-11-02 |
|---|---|
| Primary Completion Date | 2018-06-26 |
| Completion Date | 2018-06-26 |